Introduction {#sec1_1}
============

All patients undergoing surgery are at risk of complications causing significant postoperative morbidity. Surgical site infections (SSI) are among the most common healthcare-associated infections, closely followed by urinary tract infections and pulmonary infections \[[@B1]\]. SSI are not only a cause of considerable discomfort for the patient, but they are also costly, being associated with longer postoperative hospital stays, additional surgical procedures, and often higher mortality.

Rates of SSI vary widely regarding hospital and surgical procedure and may be influenced by surgical management as well as other aspects of the quality of healthcare \[[@B1],[@B2],[@B3],[@B4]\].

The rate of SSI has been proposed as a potential indicator of the quality of clinical care and management. There is clear evidence that monitoring of hospital-acquired infections is useful not only to establish surveillance but also to take appropriate measures in order to improve the quality of care \[[@B3]\]. It could be shown that an active surveillance can reduce the incidence of SSI \[[@B5]\].

The risk of developing SSI is also influenced by individual patient characteristics, type of surgery, and causative pathogens and is not exclusively caused by external factors such as clinical management \[[@B6],[@B7],[@B8]\].

Faraday et al. \[[@B9]\] could show in a prospective study published in *Annals of Surgery* in 2013 that a past history of skin infections even remote from the site of surgery is a predisposing factor for the occurrence of SSI. Adjustments for intraoperative infection risk factors and adherence to infection control best practice metrics had no impact on risk estimates. The authors also showed in their study on 613 patients that female patients had a reduced hazard ratio of 0.57 for SSI. This factor was not further specified or discussed in their publication. Very few data exist on the impact of gender with regard to the occurrence of SSI. In the study by Brandt et al. \[[@B5]\], demonstrating the beneficial effect of surveillance on rates of SSI, male sex was identified to have an increased odds ratio (OR) for SSI of 1.4 in appendectomies, 1.3 in colonic surgery, 1.2 in hip prosthesis arthroplasty, 1.7 in nephrectomy, and even 2.7 in thyroidectomies. In contrast, reduced ORs for SSI in men were noted for coronary artery bypass (0.6) and herniorraphy (0.4) \[[@B5]\].

The extensive Health Technology Assessment by Gibbons et al. \[[@B8]\] on the identification of risk factors for SSI from 2011 also addressed gender. They concluded in their analysis of 113,824 surgical procedures from the UK National Surgical Site Infection Surveillance Service that the odds for SSI clearly increased with age, but were most varied for gender. Differences could be found for female patients with lower risks of SSI after knee prosthesis procedures and open fracture reduction, while women after coronary artery bypass surgery had higher odds of SSI. The risk for large bowel operations and subsequent SSI was only slightly lower in women \[[@B8]\].

Therefore, it seems mandatory to further evaluate the question of gender as a potential risk factor for SSI.

Material and Methods {#sec1_2}
====================

The German National Nosocomial Infections Surveillance System (Krankenhaus-Infektions-Surveillance-System (KISS)) has been performing active surveillance since its establishment in 1997. It consists of different modules for surveillance of healthcare-associated infections, one being the surgery module (OP-KISS) which registers 32 types of surgical indicator procedures on a patient-based voluntary surveillance method with over 600 participating departments. KISS uses definitions of the Centers for Disease Control and Prevention \[[@B10]\]. Details of the methodology of OP-KISS have been previously described \[[@B2]\]. Data from four categories of the surgery module, i.e. orthopaedic, abdominal, cardiac, and vascular surgery, were gathered from the data pool, comprising a total of 438,050 surgical procedures which were monitored between 2005 and 2010. SSI rates were calculated with respect to gender and type of surgery and tested for statistical significance using the statistical software R 3.0.2.

Results {#sec1_3}
=======

Among all monitored surgical procedures within the German National Nosocomial Infections Surveillance System from 2005 to 2010 were 438,050 cardiac, vascular, abdominal, and orthopaedic procedures. Within these four groups a total of 8,639 SSI were registered. The general rate of SSI amounted to 1.97/100 procedures.

Of the 438,050 operated patients, 241,437 were female (55%) and 196,613 male (45%). The overall rate of SSI for women was 1.74/100 procedures, whereas in male patients SSI occurred in 2.26/100 surgeries. This difference is highly significant with p \< 0.001 (table [1](#T1){ref-type="table"}). Since rates of SSI vary considerably with the type of surgery, SSI were calculated separately for orthopaedic, abdominal, cardiac, and vascular surgery.

In orthopaedic surgery, male patients underwent a total of 96,221 procedures (38.6%), with the majority of patients being women with 153,111 (61.4%) procedures. No statistical difference could be shown for gender, with men suffering from SSI in 1.01/100 procedures and women in 0.96/100 of the cases (p = 0.27).

In abdominal surgery, the rates of operations between the sexes were similar to orthopaedics, i.e. 40.7% of the patients were men and 59.3% women, with 111,053 procedures being performed. However, the occurrence of SSI was significantly lower in women with a rate of 2.92/100, while men developed SSI in 4.37/100 of the cases (p \< 0.001).

The opposite results were found in cardiac surgery, where the majority of the 46,277 patients were male (77.9%). The SSI rate for men was 3.02/100 procedures, whereas women, accounting for only 22.1% of the cases, developed SSI in 5.5/100 procedures (p \< 0.001).

In vascular surgery, men were also more frequently operated on, accounting for 61.1% of the 31,388 cases. However, the rates of SSI in males and females did not differ (2.11 and 2.01/100 surgeries, respectively).

The underlying pathogens were isolated in 7,168 of the occurring cases of SSI (3,422 in men and 3,746 in women) (table [2](#T2){ref-type="table"}).

*Staphylococcus aureus* was the most frequently isolated pathogen, and its sensitive strain (methicillin-sensitive *S. aureus* (MSSA)) occurred more often in women than in men (p = 0.013).

No difference could be found in the methicillin-resistant strain (MRSA), where men and women showed percentages of 6.2 and 6.6 for MRSA-SSI, respectively (p = 0.497).

Enterococci, as the second most frequently isolated organism, did not differ between SSI in men and women with 23.4 and 21.6%, respectively (p = 0.067).

Infections with coagulase-negative staphylococci (CoNS) dominated in men, amounting to 18.8% of the microbiologically confirmed SSI versus 14.0% in women (p \< 0.001).

No gender differences were present in infections with *Escherichia coli*, *Enterobacter*, or *Klebsiella*. *Pseudomonas aeruginosa*, however, showed a higher incidence in women than in men (6.9 vs. 5.3%; p = 0.007).
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==========

With more than 10 million surgical procedures being annually performed in Germany, the excess healthcare costs due to SSI are immense. Any achievable reduction of the rate of SSI is of the utmost benefit for the individual patient as well as the public. Therefore, it is worthwhile to analyse gender differences in the occurrence of SSI in order to evaluate options for targeted preventive strategies.

Looking at the overall rate of SSI determined in this study, with women having significantly lower infection rates as compared to men, one might be inclined to relate this to the evolutionary differences between the sexes, known as Bateman\'s principle. It states that selection favoured an improved immune function in females in order to ensure reproduction and that the male immune suppression is the immunological cost of increased sexual activity \[[@B11]\]. As an alternative hypothesis it was argued that Bateman\'s principle does not dictate a fixed pattern but favours phenotypically plastic reproductive strategies so that neither sex is expected to possess an intrinsically superior immune function, rather showing varying immunological sex differences in response to different environments.

With reported sex disparities in inflammation, Pergola et al. \[[@B12]\] could show on a hormonal level that testosterone suppresses phospholipase D. This causes sex differences in leukotriene biosynthesis in human monocytes, which are central effector cells in immunity \[[@B12]\]. Romana-Souza et al. \[[@B13]\] demonstrated in their study that gonadal hormones differently modulate cutaneous wound healing, with androgens contributing to stress-induced impairment of the healing, whereas oestrogens did not. Androgens were shown to have a proinflammatory effect on wounds, impairing re-epithelialization, whereas oestrogens had an anti-inflammatory effect, with males and females responding differently with regard to stress \[[@B13]\]. A study on plasminogen-deficient mice demonstrated marked gender effects on wound healing \[[@B14]\]. Loss of plasmin-dependent fibrinolysis leads to abnormal wound healing and development of pseudomembranes. An accelerated wound closure was seen in female mice versus male plasmin-deficient mice. Interestingly, this gender effect could not be reversed by ovariectomy, suggesting that female sex hormones did not mediate the accelerated skin wound healing.

The above studies provide some explanations for the observed lower rates of SSI in female patients; however, looking at the different types of surgery, this is only applicable to abdominal surgery. The exact opposite was observed for women in cardiac surgery, with a much higher risk of wound infections.

Apparently, the gender differences are far more complex in order for one simplistic explanation being able to provide an answer to all disparities.

A highly interesting study by Dos Santos and Monte-Alto-Costa \[[@B15]\] published in 2013 showed that female, but not male mice exhibited delayed cutaneous wound healing following aspirin administration. Female mice treated with aspirin had lower oestradiol levels than the control group \[[@B15]\]. This could be a possible underlying mechanism for the elevated rate of SSI in women undergoing cardiac surgery, since most patients receive aspirin for cardiac protection.

It remains unexplained why there were no differences in the rates of SSI to be noted for orthopaedic or vascular surgery in our study. Data from the UK surveillance system showed a decreased risk of SSI for knee prostheses and open reductions of fractures for female gender, but no effect on hip prostheses \[[@B8]\]. Their data did not exhibit a gender difference in vascular surgery either.

Since age is a known risk factor for SSI, it is worth noting that recent research revealed gender-specific changes in the ageing of the human immune system. Marttila et al. \[[@B16]\] performed transcriptional analyses of mononuclear cells from elderly individuals and showed a clear gender bias in comparison to young controls. Of the signalling pathways affected by ageing only 29 were changed in males, whereas 48 pathways were changed in females. This highlights that there are combinatorial effects of age and gender \[[@B16]\].

Concerning the different isolates of pathogens of SSI, significant differences could be found for the sensitive strain of *S. aureus*, being more frequently isolated in women in our study, whereas CoNS had a higher rate in men (18.8 vs. 14%). *P. aeruginosa*, on the other hand, was more prevalent in women in our analysis. A current review on gender differences in the immune response to infection by McClelland and Smith \[[@B17]\] cited literature stating that *S. aureus* and *P. aeruginosa* had a higher prevalence in men. However, since no general susceptibility of one gender compared to the other with a specific microbial type can be found, the authors concluded that gender-specific differences are quite complex and that there is an interaction between gender and specific immune responses to specific microbes.

Conclusion {#sec1_5}
==========

Gender differences in SSI exist, are procedure-specific, and can change in the ageing immune system. The underlying causes of specific risks for SSI need to be further analysed with regard to the complex interaction of gender, type of procedure, age, and pharmacologic interventions so that targeted measures for prevention can be developed for each sex.
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Registered procedures from the German Nosocomial Infections Surveillance System (2005--2010) and gender-specific rates of SSI

  Type of surgery   Operated patients   SSI/100 procedures   p values[^a^](#T1F1){ref-type="table-fn"} for SSI                    
  ----------------- ------------------- -------------------- --------------------------------------------------- ---------------- ---------
  Orthopaedic       96,221 (38.6%)      153,111 (61.4%)      969 (1.01)                                          1,472 (0.96)     0.27
  Abdominal         45,162 (40.7%)      65,891 (59.3%)       1,973 (4.37)                                        1,923 (2.92)     \<0.001
  Cardiac           36,048 (77.9%)      10,229 (22.1%)       1,090 (3.02)                                        563 (5.50)       \<0.001
  Vascular          19,182 (61.1%)      12,206 (38.9%)       404 (2.11)                                          245 (2.01)       0.58
  *Total*           *196,613 (44.9%)*   *241,437 (55.1%)*    *4,436 (2.26)*                                      *4,203 (1.74)*   \<0.001

Pearson\'s Chi-squared test with Yates\' continuity correction.

###### 

Isolated pathogens of registered SSI from the German Nosocomial Infections Surveillance System (2005--2010) and gender-specific rates

  Pathogens                          SSI with specific pathogens   p values[^a^](#T2F1){ref-type="table-fn"}   
  ---------------------------------- ----------------------------- ------------------------------------------- ---------
  *Staphylococcus aureus* -- MSSA    806 (23.6)                    979 (26.1)                                  0.013
  *Staphylococcus aureus* -- MRSA    213 (6.2)                     249 (6.6)                                   0.487
  *Enterococcus* spp.                801 (23.4)                    808 (21.6)                                  0.067
  *Escherichia coli*                 725 (21.2)                    801 (21.4)                                  0.862
  Coagulase-negative staphylococci   645 (18.8)                    524 (14.0)                                  \<0.001
  *Enterobacter*                     189 (5.5)                     207 (5.5)                                   0.963
  *Pseudomonas aeruginosa*           182 (5.3)                     258 (6.9)                                   0.007
  *Klebsiella* spp.                  138 (4.0)                     156 (4.2)                                   0.825

Pearson\'s Chi-squared test with Yates\' continuity correction.
